Hydroxysafflor yellow A improves established monocrotaline-induced pulmonary arterial hypertension in rats

OBJECTIVE: To evaluate the beneficial effects of hydroxysafflor yellow A (HSYA) on monocrotaline (MCT)-induced pulmonary arterial hypertension (PAH) in rats, and to investigate the main pathophysiological mechanism of HSYA in preventing development of MCT-induced PAH. METHODS: Four groups (control,...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Xiaotong, Zhang, Yixiong, Zhou, Zhou, Zhang, Xingwen, Long, Yanfei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2016
Materias:
Research Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5536702/
https://www.ncbi.nlm.nih.gov/pubmed/27059291
http://dx.doi.org/10.1177/0300060515597931

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5536702/
https://www.ncbi.nlm.nih.gov/pubmed/27059291
http://dx.doi.org/10.1177/0300060515597931

Ejemplares similares